Vygon and Oncomfort provide personalized treatment option for medical interventions

Vygon, a group specializing in single-use medical devices, and Oncomfort, the Belgian inventor of Digital Sedation – a new method for relieving patients’ pain and anxiety without medication – have announced a commercial partnership in six European countries.

The partnership will aim to enable greater acceleration of the adoption of Digital Sedation by healthcare professionals and patients. Digital Sedation is a CE-marked medical device designed to relieve, without medication, the pain and anxiety of patients, combining hypnotherapy and integrative therapeutic techniques through virtual reality glasses. 

Vygon will offer healthcare professionals a new therapeutic option in performing their interventions. This partnership is effective immediately. 

Vygon President Stéphane Regnault said: "Vygon has long-standing experience in combined therapeutic approaches. Oncomfort's innovative technique is in line with our expansion in this field. Our international presence in hospitals and clinics allows us to integrate Oncomfort's solution into interventional approaches to ensure that the patient can benefit from the best care.” 

Oncomfort CEO Mario Huyghe added: "We are delighted to be partnering with Vygon. It has an international presence in specialties where Oncomfort's efficacy has been proven. Our method covers light to deep sedation, allowing it to be used in the different clinical areas in which Vygon is active … Together with Vygon, we will deploy configurations targeted for each clinical activity."